AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

793.051

-6.012-0.75%

Number of Gainers:18

Number of Losers:12

Number of Flat:16

PE:- -

High:799.143

Open:799.063

Low:783.855

Close:799.063

Loading ...

NewMarket Unit to Increase Ammonium Perchlorate Production Capacity

MT Newswires Live

These are the 10 most shorted ASX shares

Bioxyne Limited's (ASX:BXN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Simply Wall St.

BRIEF-CSL Launches Andembry For Prevention Of Acute Attacks In Hereditary Angioedema In Japan

CSL Launches Andembry® for the Prevention of Acute Attacks in Hereditary Angioedema (Hae) in Japan

THOMSON REUTERS

How to build the perfect ASX share portfolio

ASX Value Picks Featuring Judo Capital Holdings And Two Other Stocks With Estimated Low Valuations

Simply Wall St.

Initia Co-founder Disclosure: Binance Labs is Initia's first and largest investor

Sol-Gel- to Receive $16 Million During 2025

THOMSON REUTERS

Sol-Gel and Mayne Pharma Announce the Purchase of Epsolay® and Twyneo® in the U.S.

THOMSON REUTERS

Sol-Gel- Sgt-610 Phase Iii Trial Top-Line Results Expected Q4 2026

THOMSON REUTERS

Federal Reserve Chair Powell Suggests Easing Bank Cryptocurrency Rules

Here are the top 10 ASX 200 shares today

Mesoblast Expands Insurance Coverage for Ryoncil to 104 Million Lives in US

MT Newswires Live

Prescient Therapeutics Receives Fast Track FDA Designation for Potential Lymphoma Treatment; Shares Up 5%

MT Newswires Live

Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today

Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%

MT Newswires Live

3 ASX Growth Companies With Up To 23% Insider Ownership

Simply Wall St.

BUZZ-Australia's Prescient Therapeutics gains on FDA fast-track status for cancer drug

Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7508/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":793.05054,"timestamp":1744869599940,"preClose":799.063,"halted":0,"volume":103350539,"delay":0,"changeRate":-0.007524,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-6.012451,"latestTime":"04-17 16:00:00 AEST","open":799.063,"high":799.14325,"low":783.8547,"amount":144493067,"amplitude":0.019133,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1744848000000,1744869600000]],"turnoverRate":0.002806,"increases":15,"decrements":13,"flats":15,"marketCap":125435522064.375,"floatMarketCap":122912811649.8125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":799.14325,"amplitude":0.019133,"preClose":799.063,"low":783.8547,"latestPrice":793.05054,"volume":103350539,"delay":0,"open":799.063,"prevYearClose":936.801,"prevWeekClose":793.051,"prevMonthClose":815.605,"prevQuarterClose":815.605,"fiveDayClose":794.746,"twentyDayClose":837.06,"sixtyDayClose":904.524,"secType":"PLATE","market":"AU","turnoverRate":0.002806,"marketCap":125435522064.375,"floatMarketCap":122912811649.8125,"timestamp":1744869599940,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":18,"down":12,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529806558","title":"NewMarket Unit to Increase Ammonium Perchlorate Production Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2529806558","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529806558?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:41","pubTimestamp":1745239295,"startTime":"0","endTime":"0","summary":"NewMarket  unit American Pacific said Monday its board approved up to $100 million in capital investment to expand its ammonium perchlorate production capabilities to keep pace with solid rocket motor demand.American Pacific said the expected investment will allow it to build an additional production line, increasing capacity by over 50%, which in turn will enable American Pacific to meet the demand of the US military and space launch programs.American Pacific said the project requires the NewMarket board's approval and is currently anticipated to be completed next year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK4109","BK7508","NEU.AU","NEU"],"gpt_icon":0},{"id":"2529281641","title":"These are the 10 most shorted ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2529281641","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529281641?lang=en_us&edition=fundamental","pubTime":"2025-04-21 08:10","pubTimestamp":1745194200,"startTime":"0","endTime":"0","summary":"At the start of each week, I like to look atASIC's short position reportto find out which shares are being targeted by short sellers.This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes be a sign that something isn't quite right with a company.With that in mind, here are the 10 most shorted shares on the ASX this week according to ASIC:. Boss Energy Ltd  remains the most shorted ASX share after its short interest rose slightly to 25.7%. Short sellers are betting heavily against the uranium market.Mineral Resources Ltd  has short interest of 13.3%, which is up slightly since last week. Short sellers aren't giving up on this mining and mining services company's shares despite their 75% decline over the past 12 months.Polynovo Ltd  sneaks into the top 10 with 10.2% of its shares held short. Investors appear disappointed with the medical device company's growth given the lofty multiples its shares trade on.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/21/these-are-the-10-most-shorted-asx-shares-21-april-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7132","BK7145","PLS.AU","BK7509","BK7126","BK7095","PDN.AU","PNV.AU","LIC.AU","LOT.AU","BK7504","BK7083","LTR.AU","BK7507","MIN.AU","BOE.AU","DYL.AU","BK7508","IEL.AU"],"gpt_icon":0},{"id":"2528201160","title":"Bioxyne Limited's (ASX:BXN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?","url":"https://stock-news.laohu8.com/highlight/detail?id=2528201160","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528201160?lang=en_us&edition=fundamental","pubTime":"2025-04-19 04:02","pubTimestamp":1745006575,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at Bioxyne's  recent performance, when its stock has declined 14% over the past month. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Particularly, we will be paying attention to Bioxyne's  ROE today.Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.  Our free stock report includes 3 warning signs investors should be aware of before investing in Bioxyne.Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for Bioxyne is:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioxyne-limiteds-asx-bxn-stock-200255960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7508","BXN.AU","BK7111"],"gpt_icon":0},{"id":"2528033279","title":"BRIEF-CSL Launches Andembry For Prevention Of Acute Attacks In Hereditary Angioedema In Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2528033279","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528033279?lang=en_us&edition=fundamental","pubTime":"2025-04-18 15:03","pubTimestamp":1744959812,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Launches Andembry For Prevention Of Acute Attacks In Hereditary Angioedema In JapanApril 18 (Reuters) - CSL Ltd CSL.AX:CSL LAUNCHES ANDEMBRY® FOR THE PREVENTION OF ACUTE ATTACKS IN HEREDITARY ANGIOEDEMA (HAE) IN JAPANFurther company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2528803340","title":"CSL Launches Andembry® for the Prevention of Acute Attacks in Hereditary Angioedema (Hae) in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2528803340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528803340?lang=en_us&edition=fundamental","pubTime":"2025-04-18 15:00","pubTimestamp":1744959653,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nFWN3QV3EV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2528020777","title":"How to build the perfect ASX share portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2528020777","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528020777?lang=en_us&edition=fundamental","pubTime":"2025-04-18 07:08","pubTimestamp":1744931280,"startTime":"0","endTime":"0","summary":"Building a strong ASX share portfolio is one of the best ways to grow long-term wealth. But what does a perfect portfolio look like?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/18/how-to-build-the-perfect-asx-share-portfolio/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["WTC.AU","BK7153","MQG.AU","BK7501","IVV.AU","BK7155","BK7046","WES.AU","BK7067","BK7508","BK7099","BK7016","BK7041","BK7503","XRO.AU","BK7510","BK7511","PME.AU","BK7094","GMG.AU","NDQ.AU","CSL.AU"],"gpt_icon":1},{"id":"2528778081","title":"ASX Value Picks Featuring Judo Capital Holdings And Two Other Stocks With Estimated Low Valuations","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778081","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778081?lang=en_us&edition=fundamental","pubTime":"2025-04-18 03:34","pubTimestamp":1744918483,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a unique path, diverging from Wall Street to close above the 7,800 points level, investors are keenly observing sector performances with energy leading gains. In this environment of mixed sector outcomes and individual stock volatility, identifying undervalued stocks like Judo Capital Holdings can offer potential opportunities for those looking to capitalize on estimated low valuations.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Judo Capital Holdings is trading at A$1.73, below its estimated fair value of A$2.22, indicating it may be undervalued based on cash flows. Despite recent earnings showing a slight decline in net income to A$40.9 million for the half-year ending December 2024, Judo's earnings are forecast to grow significantly at 29.6% annually, outpacing the Australian market average of 11.7%. However, insider selling over the past quarter could be a concern for potential investors.Overview: Superloop Limited, along with its s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-value-picks-featuring-judo-193443122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7031","XJO.AU","NXL.AU","SLC.AU","XAO.AU","BK7096","MVP.AU","JDOPA.AU","VAU.AU","BK7088","GNP.AU","EOS.AU","XKO.AU","JDO.AU","BK7104","BK7115","BK7508","BK7135","BK7016","IDX.AU","3DA.AU","PNR.AU","BK7015","BK7055","ACF.AU","BK7124"],"gpt_icon":0},{"id":"2528740616","title":"Initia Co-founder Disclosure: Binance Labs is Initia's first and largest investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2528740616","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528740616?lang=en_us&edition=fundamental","pubTime":"2025-04-17 23:21","pubTimestamp":1744903260,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 17th, Zon, co-founder of the Layer 1 Rollup network Initia, stated in a social media post, \"As early as the beginning of 2023, Binance Labs  became our first investor and the largest investor to date.\"At that time, Initia was only relying on a vision and a minimal viable product  to survive, and fortunately, Binance Labs saw it. I prefer to believe that what they saw more importantly was the strength of the team we were building.\"Today's report, Initia  has been launched on Binance Launchpool.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/290179","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["MVP","MVP.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2528714955","title":"Sol-Gel- to Receive $16 Million During 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528714955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528714955?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:42","pubTimestamp":1744893775,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1FQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK4007","BK7096","BK7508","SLGL"],"gpt_icon":0},{"id":"2528714629","title":"Sol-Gel and Mayne Pharma Announce the Purchase of Epsolay® and Twyneo® in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2528714629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528714629?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:42","pubTimestamp":1744893775,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1FQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK4007","BK7096","SLGL"],"gpt_icon":0},{"id":"2528149007","title":"Sol-Gel- Sgt-610 Phase Iii Trial Top-Line Results Expected Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2528149007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528149007?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:42","pubTimestamp":1744893775,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1FQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","BK4007","MYX.AU","SLGL"],"gpt_icon":0},{"id":"2528676497","title":"Federal Reserve Chair Powell Suggests Easing Bank Cryptocurrency Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2528676497","media":"Blockbeats","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528676497?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:21","pubTimestamp":1744878060,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 17th, according to TechinAsia report, this morning Federal Reserve Chairman Powell stated during an interview at the Chicago Economic Club that in the future, regulatory restric","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/290122","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["OCC.AU","US12M.BOND","BK4096","US3Y.BOND","US2Y.BOND","BK4588","US5Y.BOND","BK4585","US30Y.BOND","US10Y.BOND","APT.USD.HKCC","US6M.BOND","US7Y.BOND","OCC","BK7067","BK4020","BK7508","TON.USD.CC","TON.USD.HKCC","APT.USD.CC"],"gpt_icon":0},{"id":"2528786795","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2528786795","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528786795?lang=en_us&edition=fundamental","pubTime":"2025-04-17 15:04","pubTimestamp":1744873451,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index (ASX: XJO) enjoyed a positive end to this short trading week today. After a volatile week, investors were clearly in a good mood this Thursday, sending the ASX 200 up 0.78%. That","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/17/here-are-the-top-10-asx-200-shares-today-17-april-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7507","BK7129","CGF.AU","LYC.AU","CU6.AU","BK7096","ALD.AU","BK7065","BK7506","BK7112","IGO.AU","BK7139","BOQ.AU","SMR.AU","ILU.AU","BK7083","KAR.AU","BK7126","BK7095","PNV.AU","BK7142","BK7508","BK7504","XJO.AU"],"gpt_icon":0},{"id":"2528732243","title":"Mesoblast Expands Insurance Coverage for Ryoncil to 104 Million Lives in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2528732243","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528732243?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:23","pubTimestamp":1744863798,"startTime":"0","endTime":"0","summary":"Mesoblast  expanded its coverage for Ryoncil to 104 million US government- and private-insured lives, according to a Thursday filing with the Australian bourse.Ryoncil is approved by the US Food and Drug Administration for mesenchymal stromal cell therapy.It is the only approved therapy for steroid-refractory acute graft versus host disease  in children aged two months and older, a separate filing showed.Mesoblast's shares were up nearly 2% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","MESO","MSB.AU","BK4139","BK7501"],"gpt_icon":0},{"id":"2528329537","title":"Prescient Therapeutics Receives Fast Track FDA Designation for Potential Lymphoma Treatment; Shares Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528329537","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528329537?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:18","pubTimestamp":1744863516,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  received a fast-track designation from the US Food and Drug Administration for its PTX-100 compound for the potential treatment of adults with relapsed or refractory mycosis fungoides, according to a Wednesday filing with the Australian bourse.The designation will expedite the review of therapies for serious conditions with high unmet need, enabling earlier delivery to patients, the filing said.Mycosis fungoides is a subtype of cutaneous T-cell lymphoma, a group of rare blood cancers affecting the skin.Shares rose nearly 5% in afternoon trade Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BYQQ9H92.USD","BK4139","FAST","LENZ","BK4585","BK7067","BK4007","IE00BFXG0V08.USD","BK4567","PTX.AU","IE00B5TLWC47.USD","BK4588","BK4104","BK7508"],"gpt_icon":0},{"id":"2528573084","title":"Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today","url":"https://stock-news.laohu8.com/highlight/detail?id=2528573084","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528573084?lang=en_us&edition=fundamental","pubTime":"2025-04-17 12:04","pubTimestamp":1744862698,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At the time of writing, the benchmark index is up 0.6% to 7,803.9 points. Four ASX shares that have failed to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/17/why-imricor-nanosonics-perpetual-and-tourism-holdings-shares-are-sinking-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","BK7126","MDR.AU","BK7508","PPT.AU","BK7125","BK7007","BK7094","BK7161","NAN.AU","IMR.AU","BK7062","THL.AU","BK7503"],"gpt_icon":0},{"id":"2528355757","title":"Imricor Receives CE Mark Approval for Electrophysiology Recording, Cardiac Simulator System; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528355757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528355757?lang=en_us&edition=fundamental","pubTime":"2025-04-17 10:51","pubTimestamp":1744858297,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said that its Advantage-MR electrophysiology recording and cardiac stimulator system received CE mark certification under the European Union's new medical device regulations regime, according to a Thursday Australian bourse filing.The commercial launch of its second-generation Vision-MR ablation catheter and the new Advantage-MR system is planned to start in June across new and existing sites in the EU.In February, the company's second-generation Vision-MR ablation catheter received CE mark approval under the medical device regulations regime.Imricor's shares fell almost 4% in recent trading on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IMR.AU","BK4585","BK4109","BK7508","BK7503","CE","BK7007"],"gpt_icon":0},{"id":"2528272737","title":"3 ASX Growth Companies With Up To 23% Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2528272737","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528272737?lang=en_us&edition=fundamental","pubTime":"2025-04-17 03:38","pubTimestamp":1744832288,"startTime":"0","endTime":"0","summary":"As the Australian market navigates a period of slower trade and investor caution amid ongoing global tensions, identifying growth companies with significant insider ownership can offer valuable insights into potential investment opportunities. In this environment, where confidence is tempered by geopolitical uncertainties, stocks with strong insider commitment may signal a higher level of trust in the company's long-term prospects.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 93 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Aurelia Metals Limited is an Australian company involved in the exploration and production of mineral properties, with a market capitalization of A$456.99 million.Operations: The company's revenue is primarily derived from its operations at the Peak Mine , Dargues Mine , and Hera Mine .Clarity Pharmaceuticals demonstrates strong growth potential, driven by its innovati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-companies-23-193808763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["CU6.AU","PLT.AU","BK7116","BK7506","CYC.AU","EIQ.AU","IPX.AU","IMA.AU","XAO.AU","AMI.AU","AAL.AU","BK7096","FEX.AU","TTT.AU","BK7007","BBT.AU","XJO.AU","BK7093","NWF.AU","ACR.AU","BK7508","XKO.AU","BK7016","BK7036","IPX","BK7095","BK7077","BK7078","BK7129"],"gpt_icon":0},{"id":"2527401260","title":"BUZZ-Australia's Prescient Therapeutics gains on FDA fast-track status for cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2527401260","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527401260?lang=en_us&edition=fundamental","pubTime":"2025-04-16 09:35","pubTimestamp":1744767341,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Prescient Therapeutics gains on FDA fast-track status for cancer drug** Shares of Prescient Therapeutics PTX.AX rise as much as 28.6% to A$0.054, hit their highest levels since February 11** The clinical-stage oncology co says it received the US FDA Fast-Track designation for PTX-100, a treatment for adults with relapsed or refractory mycosis fungoides** PTX-100 is a compound with the ability to block an important cancer growth enzyme, says co** The fast-track status is an important step towards commercialisation of the drug, says co** About 2.7 million shares change hands, 4.3 times the 30-day average volume of shares** Stock down 16% this year, as of last close  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL4N3QU034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTX.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2527405917","title":"Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2527405917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527405917?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:57","pubTimestamp":1744765044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":123,"code":"91000000","status":"200"}]}}